These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 325142)

  • 1. Macrophage function in tumor-bearing mice: tumoricidal and chemotactic responses of macrophages activated by infection with Mycobacterium bovis, strain BCG.
    Meltzer MS; Stevenson MM
    J Immunol; 1977 Jun; 118(6):2176-81. PubMed ID: 325142
    [No Abstract]   [Full Text] [Related]  

  • 2. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures.
    Ruco LP; Meltzer MS
    J Immunol; 1977 Sep; 119(3):889-96. PubMed ID: 330759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mode of immunopotentiating action of BCG: macrophage activation produced by BCG-infection.
    Ishibashi T; Harada S; Takamoto M; Harada Y; Yamada H; Miyazaki N; Sugiyama K
    Jpn J Exp Med; 1978 Feb; 48(1):35-40. PubMed ID: 353337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Destruction of tumor cells by BCG-activated alqolar macrophages.
    Zwilling BS; Campolito LB
    J Immunol; 1977 Sep; 119(3):838-41. PubMed ID: 330756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and functional characteristics of the plasma membrane of macrophages from BCG-infected mice.
    Edelson PJ; Erbs C
    J Immunol; 1978 May; 120(5):1532-6. PubMed ID: 351053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cytotoxicity in vitro by macrophages from mice infected with mycobacterium bovis strain BCG.
    Cleveland RP; Meltzer MS; Zbar B
    J Natl Cancer Inst; 1974 Jun; 52(6):1887-95. PubMed ID: 4857796
    [No Abstract]   [Full Text] [Related]  

  • 7. Defective tumoricidal capacity of macrophages from A/J mice. II. Comparison of the macrophage cytotoxic defect of A/J mice with that of lipid A-unresponsive C3H/HeJ mice.
    Boraschi D; Meltzer MS
    J Immunol; 1979 Apr; 122(4):1592-97. PubMed ID: 376721
    [No Abstract]   [Full Text] [Related]  

  • 8. Bovine natural killer cells restrict the replication of Mycobacterium bovis in bovine macrophages and enhance IL-12 release by infected macrophages.
    Denis M; Keen DL; Parlane NA; Storset AK; Buddle BM
    Tuberculosis (Edinb); 2007 Jan; 87(1):53-62. PubMed ID: 16730232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective tumoricidal capacity of macrophages from C3H/HeJ mice.
    Ruco LP; Meltzer MS
    J Immunol; 1978 Jan; 120(1):329-34. PubMed ID: 627723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents.
    Germain RN; Williams RM; Benacerraf B
    J Natl Cancer Inst; 1975 Mar; 54(3):709-20. PubMed ID: 1091741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of genetic defects in macrophage tumoricidal capacity: identification of murine strains with abnormalities in secretion of cytolytic factors and ability to bind neoplastic targets.
    Adams DO; Marino PA; Meltzer MS
    J Immunol; 1981 May; 126(5):1843-7. PubMed ID: 6783698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of Mycobacterium bovis (Bacillus Calmette-Guérin) on macrophage random migration, chemotaxis, and pinocytosis.
    Poplack DG; Sher NA; Chaparas SD; Blaese RM
    Cancer Res; 1976 Apr; 36(4):1233-7. PubMed ID: 769964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCG-induced murine effector cells. I. Cytolytic activity in peritoneal exudates: an early response to BCG.
    Tracey DE; Wolfe SA; Durdik JM; Henney CS
    J Immunol; 1977 Sep; 119(3):1145-51. PubMed ID: 330748
    [No Abstract]   [Full Text] [Related]  

  • 14. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated macrophages and the antitumor action of BCG.
    Alexander P
    Natl Cancer Inst Monogr; 1973 Dec; 39():127-33. PubMed ID: 4595313
    [No Abstract]   [Full Text] [Related]  

  • 16. Defective tumoricidal capacity of macrophages from A/J mice. III. Genetic analysis of the macrophage defect.
    Boraschi D; Meltzer MS
    J Immunol; 1980 Mar; 124(3):1050-3. PubMed ID: 6987306
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of Myobacterium bovis (strain Bacillus Calmette-Guérin) on macrophage production by the bone marrow of tumor-bearing mice.
    Fisher B; Taylor S; Levine M; Saffer E; Fisher ER
    Cancer Res; 1974 Jul; 34(7):1668-70. PubMed ID: 4599359
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental studies of tumor immunotherapy. II. Tumor immunotherapy following tumor extirpation.
    Hayashi S
    Acta Med Okayama; 1976 Jun; 30(3):197-208. PubMed ID: 136871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumoricidal responses in vitro of peritoneal macrophages from conventionally housed and germ-free nude mice.
    Meltzer MS
    Cell Immunol; 1976 Mar; 22(1):176-81. PubMed ID: 776413
    [No Abstract]   [Full Text] [Related]  

  • 20. Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1979 Apr; 122(4):1587-91. PubMed ID: 376720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.